Contextualising COVID-19 in 2024
Gregory Walker and William RawlinsonReferences
1 Bennett CM, Vally H (2024) The evolving epidemiology of SARS-CoV-2. Microbiol Aust 44, 4-7.
| Crossref | Google Scholar |
2 Michie A (2024) Wastewater-based SARS-CoV-2 surveillance and sequencing. Microbiol Aust 44, 8-12.
| Crossref | Google Scholar |
3 Gracie NP et al. (2024) Cellular signalling by SARS-CoV-2 spike protein. Microbiol Aust 44, 13-17.
| Crossref | Google Scholar |
4 Grohmann G, Booy R (2024) An update on Long COVID. Microbiol Aust 44, 18-21.
| Crossref | Google Scholar |
5 Barnard RT, Siegel EB (2024) A brief survey of interventional agents intended to treat Long COVID. Microbiol Aust 44, 22-26.
| Crossref | Google Scholar |
6 Triccas JA, Steain MC (2024) Australia’s COVID-19 vaccine journey: progress and future perspectives. Microbiol Aust 44, 27-31.
| Crossref | Google Scholar |
7 Harvey E, Foster CSP (2024) Emerging viral threats in Australia. Microbiol Aust 44, 32-37.
| Crossref | Google Scholar |
8 Sutton B (2024) Pandemic lessons learned and future public health strategies. Microbiol Aust 44, 38-40.
| Crossref | Google Scholar |
9 World Health Organisation (2022) 2022 Progress report on the Global Action Plan for Healthy Lives and Well-being for All. Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals – Incentivizing collaboration. WHO. Available at https://www.who.int/initiatives/sdg3-global-action-plan/progress-and-impact/progress-reports/2022/principals-quotes
10 Hampshire A et al. (2024) Cognition and memory after COVID-19 in a large community sample. N Eng J Med 390(9), 806-818.
| Crossref | Google Scholar | PubMed |